2015 International Meeting: Translating Science Into Survival May 11, 2015December 14, 2022 Michelle Liew The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to join forces to sponsor the Inaugural International Cancer Immunotherapy Conference, which will take place at the Sheraton Times Square in New York City on September 16-19, 2015. Entitled “Translating Science into Survival,” the meeting will feature more than 60 talks by acknowledged leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy including: immune regulation of T cell responsiveness genomic methods for identifying tumor antigens the tumor microenvironment T cell therapies checkpoint blockade biomarkers combinations microbiome This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates. This collaborative meeting will be held every other year, in lieu of each organization’s individual meeting, and will alternate between the United States and Europe. We believe that by combining our efforts we can be more effective and efficient in disseminating the latest cutting-edge information. Scientific Planning Committee: James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, TX Cedrik M. Britten, Association for Cancer Immunotherapy (CIMT), Mainz, Germany Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Alexander M. M. Eggermont, Institut Gustave Roussy, Paris, France Carl G. Figdor, Radboud University of Nijmegen, Nijmegen, The Netherlands Wolf-Hervé Fridman, Centre de Recherche des Cordeliers, Paris, France Philip D. Greenberg, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA Axel Hoos, GlaxoSmithKline, Collegeville, PA Elizabeth M. Jaffee, Johns Hopkins University, Baltimore, MD Peter W. M. Johnson, University of Southampton, Southampton, United Kingdom Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France Nils Lonberg, Bristol-Myers Squibb, Milpitas, CA Cornelis J. M. Melief, Leiden University Medical Center, Leiden, The Netherlands Ellen Puré, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA Robert D. Schreiber, Washington University, St. Louis, MO Continuing Medical Education Activity – AMA PRA Category 1 Credits™ available Deadlines to submit your abstracts isJune 10, 2015, and advanced registration is July 27, 2015. For more information, contact Lynne Harmer, or visit www.cancerimmunotherapyconference.org. Read more: Post navigation Watching AACR from Near and Far Read Story CRI’s Insights for ASCO 2015 Read Story